Kapka Miteva | Health Professions | Excellence in Research Award

Published on by Citation Awards

Kapka Miteva | Health Professions | Excellence in Research Award

University of Geneva, Faculty of Medicine | Switzerland

Dr. Kapka Miteva is a researcher in molecular medicine whose work spans regenerative therapies, cardiovascular repair, and high-dimensional analysis of inflammatory mechanisms in heart disease. She earned a master’s degree in Molecular Medicine from Charité University Medical School in Berlin, where she also began her scientific career at the BIH Center for Regenerative Therapies, focusing on regenerative and cardiovascular repair strategies. Her early research achievements culminated in a PhD awarded with summa cum laude, followed by a prestigious Career Development Grant through the Lydia Rabinowitsch Scholarship to support her postdoctoral studies at the same institute. Dr. Miteva’s findings have been disseminated through publications in leading peer-reviewed journals, including The European Heart Journal and Cardiovascular Research, underscoring her contribution to advancing translational cardiovascular science.

Citation Metrics (Scopus)

2000

1500

1000

500

0

Citations
1,834

Documents
45

h-index
22

                               Citations
         Documents
       h-index


View Scopus Profile

Featured Publications

Wayne McCormick | Medicine and Dentistry | Excellence in Citation Achievement Award

Published on by Citation Awards

Wayne McCormick | Medicine and Dentistry | Excellence in Citation Achievement Award

University of Washington | United States

Dr. Wayne C. McCormick, MD, MPH, FACP, is a distinguished Professor of Medicine at the University of Washington School of Medicine, where he holds the William Colson Endowed Chair in Gerontology and Geriatric Medicine. As Division Head of Gerontology and Geriatric Medicine, he has provided exceptional leadership in advancing clinical care, education, and research in aging and palliative medicine. A graduate of Washington University Medical School and the University of Washington School of Public Health, Dr. McCormick completed his medical training at Michael Reese Hospital in Chicago, where he served as Chief Medical Resident before joining the University of Washington faculty in 1990. Over his decades-long career, he has made significant contributions to the fields of geriatrics, hospice, and palliative medicine, serving as Program Director of the Palliative Medicine Fellowship and Director of Palliative Care Services at Harborview Medical Center. He has been recognized with numerous honors, including multiple “Top Doctor” awards from Seattle Magazine and the Harborview Cares Service Excellence Award. A Fellow of the American College of Physicians and past president of both the American Academy of Home Care Physicians and the American Geriatrics Society, Dr. McCormick has played a vital role in shaping national standards for elder care and end-of-life practice. His editorial work for leading journals such as the New England Journal of Medicine and Journal of the American Geriatrics Society underscores his scholarly influence. Deeply committed to mentorship, he has guided generations of medical students, residents, and fellows. Through his extensive leadership, teaching, and clinical service, Dr. McCormick has made enduring contributions to improving the quality of life for older adults and advancing excellence in geriatric and palliative medicine.

Profile: Scopus 

Featured Publications

  • Lee, C. S., Gibbons, L. E., Lee, A. Y., Yanagihara, R. T., Blazes, M. S., Lee, M. L., McCurry, S. M., Bowen, J. D., McCormick, W. C., Crane, P. K., & Larson, E. B. (2022). Association between cataract extraction and development of dementia. JAMA Internal Medicine, 182(2), 134-141.

  • Mohammed, A., Gibbons, L. E., Gates, G., Anderson, M. L., McCurry, S. M., McCormick, W., … Larson, E. B. (2022). Association of performance on dichotic auditory tests with risk for incident dementia and Alzheimer dementia. JAMA Otolaryngology–Head & Neck Surgery, 148(1), 20-27.

  • Alzheimer’s Disease Genetics Consortium. (2022). Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90. Scientific Reports, 12(1),

  • Bellenguez, C., Küçükali, F., Jansen, I. E., Amin, N., Ahmad, S., Lovestone, S., Smith, A. D., Warden, D., Wilcock, G., Laitinen, T., van Duijn, C. M., … (and many others) (2022). New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nature Genetics, 54(4), 412-436.

  • Lee, C. S., … (2023). Diabetic retinopathy and dementia association, beyond diabetes severity. American Journal of Ophthalmology.

Xiangyu Zhong | Medicine | Best Researcher Award

Published on by Citation Awards

Prof. Xiangyu Zhong | Medicine | Best Researcher Award

Prof. Xiangyu Zhong, The 2nd Affiliated Hospital of Harbin Medical University, China

Professor Xiangyu Zhong is a distinguished academic and chief physician at the Department of General Surgery, The 2nd Affiliated Hospital of Harbin Medical University, China. With a robust background in medicine and extensive clinical experience, his research primarily focuses on cholangiocarcinoma, Metabolic Associated Fatty Liver Disease (MAFLD), and hepatic ischemia-reperfusion injury.

Professional Profiles:

Scopus

Professional Experience:

Prof. Xiangyu Zhong is a distinguished academician with a robust educational background in medicine. He serves as a Professor and Chief Physician in the Department of General Surgery at the Second Affiliated Hospital of Harbin Medical University. With extensive clinical expertise, he has significantly contributed to medical research, particularly in the fields of cholangiocarcinoma, Metabolic Associated Fatty Liver Disease (MAFLD), and hepatic ischemia-reperfusion injury. His academic journey is complemented by 57 publications in SCI/Scopus indexed journals, with a citation index of 1172, solidifying his position as a leading researcher in his field.

Research Interests:

Prof. Zhong’s research is focused on cholangiocarcinoma, MAFLD, and hepatic ischemia-reperfusion injury. His work has substantially enhanced the understanding of these diseases, offering valuable insights into their pathogenesis and potential therapeutic approaches. With three ongoing research projects, his contributions continue to shape the future of clinical treatments and patient care in liver diseases. Although there are no consultancy or industry projects, Prof. Zhong’s research alone has garnered significant recognition, evidenced by his numerous publications and citation index. His contributions have directly impacted advancements in surgical techniques and liver disease management.

Contributions and Impact:

Prof. Zhong’s impactful research has led to significant advancements in understanding complex liver diseases such as cholangiocarcinoma, MAFLD, and hepatic ischemia-reperfusion injury. His work, which has been cited over 1,100 times, is widely recognized for providing new insights and therapeutic approaches that directly benefit patient care. The depth of his research has influenced both the scientific community and clinical practices, furthering knowledge in areas critical for the treatment of liver-related ailments. With a high citation index and numerous peer-reviewed publications, his work continues to drive innovation in liver surgery and related fields.

Publications:

Circ_0007534 Promotes Cholangiocarcinoma Stemness and Resistance to Anoikis through DDX3X-Mediated Positive Feedback Regulation of Parental Gene DDX42
Liu, S., Guan, C., Sha, X., Zhong, X., Jiang, X.
Cellular Signalling, 2024, 118, 111141

Open access

0 citations

Utilization of 3D Printing Technology in Hepatopancreatobiliary Surgery
Shi, W., Wang, J., Gao, J., Cui, Y., Zhong, X.
Journal of Zhejiang University: Science B, 2024, 25(2), pp. 123–134

Open access

1 citation

Forkhead Box O1 in Metabolic Dysfunction-Associated Fatty Liver Disease: Molecular Mechanisms and Drug Research
Sha, X., Zou, X., Liu, S., Zhong, X., Jiang, X.
Frontiers in Nutrition, 2024, 11, 1426780

Open access

1 citation

Research Progress and Applications of Epigenetic Biomarkers in Cancer
Gao, J., Shi, W., Wang, J., Zhong, X., Cui, Y.
Frontiers in Pharmacology, 2024, 15, 1308309

Open access

1 citation

Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
Gao, J., Wang, J., Guan, C., Xu, X., Zhong, X.
Journal of Cancer, 2024, 15(8), pp. 2214–2228

Open access

0 citations

Ferroptosis: New Strategies and Ideas for the Treatment of Pancreatic Ductal Adenocarcinoma
Yang, C., Dong, Q., Bao, H., Xu, Y., Zhong, X.
Frontiers in Bioscience – Landmark, 2024, 29(1), 45

Open access

0 citations

Cullin-Associated and Neddylation-Dissociated Protein 1 (CAND1) Alleviates NAFLD by Reducing Ubiquitinated Degradation of ACAA2
Huang, X., Liu, X., Li, X., Yang, B., Pan, Z.
Nature Communications, 2023, 14(1), 4620

Open access

5 citations

Retraction: The Prognostic Potential and Carcinogenesis of Long Non-Coding RNA TUG1 in Human Cholangiocarcinoma
Xu, Y., Leng, K., Li, Z., Jiang, X., Cui, Y.
Oncotarget, 2023, 14, pp. 779

Retraction

0 citations

Application of Normothermic Regional Perfusion in Controlled Donation After Cardiac Death Liver Transplant Donors
Zou, X., Huang, Z., Shi, W., Cui, Y., Zhong, X.
China Journal of General Surgery, 2023, 32(7), pp. 1087–1096

Open access

1 citation

Exosomal miRNAs in the Microenvironment of Pancreatic Cancer
Zou, X., Huang, Z., Guan, C., Xu, Y., Zhong, X.
Clinica Chimica Acta, 2023, 544, 117360

Open access

1 citation

Conclusion:

Prof. Xiangyu Zhong is undoubtedly a strong contender for the Best Researcher Award due to his extensive research contributions, leadership in collaborative efforts, and impact on medical and therapeutic advancements. While there are areas where improvement could further elevate his profile, such as increasing citations and expanding clinical research involvement, his overall academic impact, innovation, and leadership make him a deserving candidate. His work not only contributes to fundamental science but also holds significant promise for improving patient care and treatment outcomes, which is at the core of the Best Researcher Award’s mission.